RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 86 filers reported holding RELMADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 195,415 | $586 | 0.05% |
| Pegasus Asset Management, Inc. | 26,958 | $80,874 | 0.04% |
| RBF Capital, LLC | 194,074 | $582,222 | 0.04% |
| Opaleye Management Inc. | 30,000 | $90,000 | 0.03% |
| MGO ONE SEVEN LLC | 100,000 | $300,000 | 0.02% |
| Ikarian Capital, LLC | 40,369 | $121,107 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 1,172,723 | $3,513 | 0.02% |
| Sargent Investment Group, LLC | 16,206 | $48,618 | 0.01% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 10,000 | $30,000 | 0.01% |
| Tortoise Investment Management, LLC | 21,676 | $65,028 | 0.01% |
External links
This page lists RELMADA THERAPEUTICS INC's shareholders in Q3 2023. To view RELMADA THERAPEUTICS INC's shareholder history, click here.